Cellebrite DI (CLBT) Cash & Current Investments (2020 - 2025)

Cellebrite DI (CLBT) has reported Cash & Current Investments for 6 consecutive years, with $285.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Current Investments fell 17.34% year-over-year to $285.5 million; the TTM figure through Dec 2025 stood at $285.5 million (down 17.34% YoY), while the FY2025 annual figure was $285.5 million, down 17.34% from the prior year.
• Cash & Current Investments came in at $285.5 million for Q4 2025 at Cellebrite DI, up from $281.4 million in the prior quarter.
• The five-year high for Cash & Current Investments was $345.4 million in Q4 2024, with the low at $84.6 million in Q3 2022.
• Average Cash & Current Investments over 5 years is $156.3 million, with a median of $129.0 million recorded in 2022.
• The largest YoY upside for Cash & Current Investments was 106.35% in 2025 against a maximum downside of 26.1% in 2025.
• Year by year, Cash & Current Investments stood at $146.0 million in 2021, then retreated by 9.38% to $132.3 million in 2022, then jumped by 72.51% to $228.2 million in 2023, then jumped by 51.35% to $345.4 million in 2024, then slipped by 17.34% to $285.5 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $285.5 million, $281.4 million, and $179.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.